Chemokine receptor expression on monocytes from healthy individuals
- 20 October 2015
- journal article
- Published by Elsevier BV in Clinical Immunology
- Vol. 161 (2), 348-353
- https://doi.org/10.1016/j.clim.2015.09.012
Abstract
No abstract availableKeywords
Funding Information
- Stockholms Läns Landsting (ALF20130181)
This publication has 14 references indexed in Scilit:
- A Randomized Controlled Trial of the Efficacy and Safety of CCX282-B, an Orally-Administered Blocker of Chemokine Receptor CCR9, for Patients with Crohn’s DiseasePLOS ONE, 2013
- HLA-DRhi and CCR9 Define a Pro-Inflammatory Monocyte Subset in IBDClinical and Translational Gastroenterology, 2012
- Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsetsBlood, 2011
- Emerging concepts and approaches for chemokine-receptor drug discoveryExpert Opinion on Drug Discovery, 2010
- Blood Monocytes: Development, Heterogeneity, and Relationship with Dendritic CellsAnnual Review of Immunology, 2009
- CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxisBlood, 2008
- CCR7 and its ligands: balancing immunity and toleranceNature Reviews Immunology, 2008
- Chemokines — Chemotactic Cytokines That Mediate InflammationThe New England Journal of Medicine, 1998
- CCR3 and CCR5 are co-receptors for HIV-1 infection of microgliaNature, 1997
- The human leukocyte antigens and their relationship to infectionThe American Journal of Surgery, 1993